| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $871K | — | +6.1% |
| Cost of Revenue | $1.5M | — | +345.8% |
| R&D Expense | $8.4M | — | -33.1% |
| SG&A Expense | $37.9M | — | +50.7% |
| Operating Income | -$293.5M | — | -642.3% |
| Interest Expense | $11.5M | — | +6040.1% |
| Pre-tax Income | -$405.8M | — | -1179.0% |
| Income Tax | $99K | — | — |
| Net Income | -$405.9M | — | -1179.3% |
| EPS (Basic) | -$1.47 | — | -950.0% |
| EPS (Diluted) | -$1.47 | — | -950.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $249.1M | +85.1% | +70.4% |
| Short-term Investments | $207.4M | -32.0% | -66.2% |
| Accounts Receivable | $222K | -9.4% | +569.5% |
| Current Assets | $1.05B | -12.6% | +37.1% |
| Total Assets | $2.24B | -15.0% | +143.4% |
| Current Liabilities | $980.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.9M | — | +283.7% |
| Capital Expenditures | $7K | — | +128.1% |
| Investing Cash Flow | $95.7M | — | +1617.3% |
| Financing Cash Flow | $81K | — | +101.0% |
| Free Cash Flow | $17.9M | — | +283.6% |
| +4809.7% |
| Long-term Debt | $958.6M | +1.2% | — |
| Total Liabilities | $983.5M | +0.1% | +3511.6% |
| Stockholders' Equity | $1.25B | -23.9% | +40.5% |